USPTO serial 90798758
TAKE2
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 26, 2023
- Examiner
- NADELMAN, ANDREA KOYNER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TAKE2?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tama L. Drenski
Tama L. Drenski RENNER, KENNER, GREIVE, BOBAK, TAYLOR & WEBER106 S. MAIN STREETSUITE 400AKRON, OH 44308-1412Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | DNA screening for scientific research purposes; providing diagnostic services for others in the fields of science, namely, providing reagent sample diagnostic services for scientific research purposes and scientific research related thereto; providing reagent sample testing services for others in the fields of science and scientific research related thereto; computer services in the field of pharmaceutical and health care computer products, namely, computer diagnostic services and computer graphics services; providing an on-line network environment featuring technology that enables users to store, analyze and share data in the fields of life science; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment; consulting services in the field of genetic science and scientific research related thereto; providing temporary use of on-line non-downloadable software for the custom design and ordering of assays and reagents; design and development of computer software for use in analysis of biomolecules relating to diagnosing or screening cancer; design and development of computer software for use in analysis of biomolecules relating to studying genetics and DNA; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to diagnosing or screening cancer; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to studying genetics and DNA; design and development of computer software for use in Software as a Service (SaaS) services for use in genetic and bioinformatics analysis; product development of products used in the fields of scientific and clinical research; product research and development services for others in the field of chemicals and reagents for use as diagnostics, and other utilities, and for use in chemical screening and diagnostic services; product research and development services for others in the field of pharmaceutical and health care products; laboratory research in the field of gene sequencing utilizing testing probes and analytic software; database development services; biotechnology research; scientific research services in the nature of chemical screening analysis for scientific research purposes; product research and development services for others in the field of chemicals and reagents for use as diagnostics, therapeutics, herbicides, cytotoxic agents, and other utilities, and for use in chemical screening and diagnostic services for others; product research, development and design of pharmaceutical and health care products; laboratory analysis in the field of nucleic acids and proteins, among which the analysis of nucleic acids and proteins for detection purposes and monitoring, testing and approving the quality specification of same; medical and scientific research in the field of cancer detection and treatment | ACTIVE | — |
| 044 | Medical services; medical diagnostic testing and reporting services; clinical diagnostic services, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals, all for medical purposes; genetic testing for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Take2 Health Limited
- Other trademarks owned by Take2 Health Limited
- Other trademarks owned by Take2 Health Limited
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TAKE2
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 26, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 26, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 22, 2023 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Aug 22, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 18, 2023 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 18, 2023 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jul 18, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 23, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 28, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 28, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 28, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 1, 2021 | NWAP | NEW APPLICATION ENTERED | — |